MedWatch

Demant and GN ramp up investments – with money to spare

Demant and GN Store Nord have launched share buyback programs and are giving a record amount of money back to shareholders. The CFOs state that both companies have money left to invest.

Demant CFO René Schneider and CEO Søren Nielsen | Photo: Demant / PR

Demant and GN Store Nord are currently attracting attention for being two of the largest listed companies to send piles of money back to their shareholders, according to Danish media Børsen.

Each company has launched a share buyback program worth DKK 2.5bn (USD 408.9m). Investors and analysts would rather put the money towards investments in growth-generating initiatives, but Demant Chief Financial Officer René Schneider however holds that there is room for that – and then some.

Read the whole article

Get 14 days free access.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Orphazyme cuts guidance following FDA setback

Friday's disappointing rejection letter from the US FDA is affecting Orphazyme's guidance for 2021. Now, the biotech firm forecasts an operating deficit of DKK 670-700m, up from DKK 100-150m.

Further reading

Related articles

Latest news

See all jobs